Delivery Order SPE2DB20D2104-SPE2DB21FT66L
- Not listed
- This federal contract award is for the delivery of Trintellix 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $5,914.65. The contract has an ultimate completion date of May 2, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., and both companies are registered in the System for Award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,503.76 firm fixed-price delivery order is for the supply of Trintellix 5 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of August 17, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to the U.S. government, with a...
- This federal contract award is for the delivery of Trintellix 10 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,918.41 and an ultimate completion date of July 22, 2022. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 20 mg tablets. The $7,751.58 contract was awarded on June 8, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,153.09, is for the delivery of Trintellix 5 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary...
- This contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trintellix 5 mg tablets. The contract, valued at $10,931.62, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, worth up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Trintellix 20 mg tablets. The contract, valued at $2,147.31, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award is for the delivery of TRINTELLIX 10 MG tablets to the U.S. Department of Defense through the Medical Supply Chain program of the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $1,301.17 and a performance period through April 15, 2024. This order is issued...
- The Defense Logistics Agency (DLA) awarded a $2,343.74 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 20 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRINTELLIX 10 MG TABLET 30S, a specialty medication. The award has a ceiling value of $3,046.89 and an ultimate completion date of August 4, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds significant Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FT66LDelivery Order
This federal contract award is for the delivery of Trintellix 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides medical products to federal government agencies. The contract, valued at $4,199.77, is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/13/21 |